Profil
Lisa Jordan Dunlea is the founder of XableCath, Inc. founded in 2014, where she holds the titles of President, Chief Executive Officer & Director.
She currently holds director positions at Coherex Medical, Inc. and VeraLight, Inc. Ms. Dunlea has held director positions at Applied Spine Technologies, Inc., Solace Therapeutics, Inc., Lineagen, Inc., Aspen Avionics, Inc., Numira, Inc., Poseidon Medical, Inc., Athena Feminine Technologies, Inc., Oxford Bioscience Partners, vSpring Capital LLC, Spray Venture Partners LP, GE HealthCare Ceská republika sro, Cordis Endovascular Systems, Inc., The Cleveland Clinic Foundation, and Signal Peak Ventures LLC.
She was also a Principal at Oxford Bioscience Partners, Spray Venture Partners LP, GE HealthCare.
Ceská republika sro, Cordis Endovascular Systems, Inc., and The Cleveland Clinic Foundation.
Ms. Dunlea's former positions also include Aerospace Engineer at The Pratt & Whitney Co., Inc. and Chief Operating Officer at Deep Vein Medical, Inc. She received a graduate degree from Florida International University and an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Lisa Jordan Dunlea
| Sociétés | Poste | Début |
|---|---|---|
VeraLight, Inc.
VeraLight, Inc. Medical SpecialtiesHealth Technology Develops noninvasive technologies for the disease detection and health monitoring of diabetes epidemics | Directeur/Membre du Conseil | - |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects | Directeur/Membre du Conseil | - |
XableCath, Inc.
XableCath, Inc. Medical SpecialtiesHealth Technology Manufactures catheters for treatment of vascular diseases | Fondateur | 01/01/2014 |
Anciens postes connus de Lisa Jordan Dunlea
| Sociétés | Poste | Fin |
|---|---|---|
vSpring Capital LLC
vSpring Capital LLC Investment ManagersFinance vSpring Capital focuses on seed and early-stage investments in information technology and life sciences companies located in the Rocky Mountain region of the US. The firm also opportunistically invests in later-stage companies under special circumstances. They look for companies that have the potential to become significant stand-alone businesses. When considering a potential investment, vSpring Capital considers the company's potential for capital appreciation. The firm seeks companies with exceptional management teams, large markets and barriers to entry. Companies should also have a business model with the potential for large margins and significant free cash flow, and a reasonable valuation at the time of investment that will provide a substantial return-on-investment opportunity commensurate with risk. Investments range from $250,000 to $5 million. vSpring Capital typically makes initial investments of $2 million to $3 million, with the expectation of investing up to $5 million over the life of a company | Private Equity Investor | 02/04/2012 |
Deep Vein Medical, Inc.
Deep Vein Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and prosthetic venous valves | Directeur des opérations | - |
Athena Feminine Technologies, Inc.
Athena Feminine Technologies, Inc. Industrial ConglomeratesProducer Manufacturing Develops, produces, and markets health products | Directeur/Membre du Conseil | - |
Aspen Avionics, Inc.
Aspen Avionics, Inc. Aerospace & DefenseElectronic Technology Manufactures and distributes advanced technology aviation products | Directeur/Membre du Conseil | - |
Numira, Inc.
Numira, Inc. Medical/Nursing ServicesHealth Services Develops and provides molecular imaging technologies for scientific discovery and drug development | Directeur/Membre du Conseil | - |
Formation de Lisa Jordan Dunlea
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Applied Spine Technologies, Inc.
Applied Spine Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical treatment devices | Health Technology |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects | Health Technology |
Solace Therapeutics, Inc.
Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops non-surgical treatments for common bladder disorders | Health Technology |
Lineagen, Inc.
Lineagen, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic evaluation services | Health Services |
vSpring Capital LLC
vSpring Capital LLC Investment ManagersFinance vSpring Capital focuses on seed and early-stage investments in information technology and life sciences companies located in the Rocky Mountain region of the US. The firm also opportunistically invests in later-stage companies under special circumstances. They look for companies that have the potential to become significant stand-alone businesses. When considering a potential investment, vSpring Capital considers the company's potential for capital appreciation. The firm seeks companies with exceptional management teams, large markets and barriers to entry. Companies should also have a business model with the potential for large margins and significant free cash flow, and a reasonable valuation at the time of investment that will provide a substantial return-on-investment opportunity commensurate with risk. Investments range from $250,000 to $5 million. vSpring Capital typically makes initial investments of $2 million to $3 million, with the expectation of investing up to $5 million over the life of a company | Finance |
The Pratt & Whitney Co., Inc.
The Pratt & Whitney Co., Inc. Aerospace & DefenseElectronic Technology Manufactures and sells engines, helicopters, elevators and heating systems | Electronic Technology |
Spray Venture Partners LP
Spray Venture Partners LP Investment ManagersFinance Spray Venture Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Florida International University
Florida International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GE HealthCare Ceská republika sro
GE HealthCare Ceská republika sro Medical DistributorsDistribution Services Distributes and services medical equipment | Distribution Services |
Aspen Avionics, Inc.
Aspen Avionics, Inc. Aerospace & DefenseElectronic Technology Manufactures and distributes advanced technology aviation products | Electronic Technology |
VeraLight, Inc.
VeraLight, Inc. Medical SpecialtiesHealth Technology Develops noninvasive technologies for the disease detection and health monitoring of diabetes epidemics | Health Technology |
Numira, Inc.
Numira, Inc. Medical/Nursing ServicesHealth Services Develops and provides molecular imaging technologies for scientific discovery and drug development | Health Services |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and sells stent systems for the treatment of bifurcation lesions | Health Technology |
Cordis Endovascular Systems, Inc. | |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Athena Feminine Technologies, Inc.
Athena Feminine Technologies, Inc. Industrial ConglomeratesProducer Manufacturing Develops, produces, and markets health products | Producer Manufacturing |
Signal Peak Ventures LLC
Signal Peak Ventures LLC Investment ManagersFinance Run Ventures invests in companies located in the United States. The firm targets companies operating in the fields of technology services sector. It provides financing for early stage capital transactions. | Finance |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deep Vein Medical, Inc.
Deep Vein Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and prosthetic venous valves | Health Technology |
XableCath, Inc.
XableCath, Inc. Medical SpecialtiesHealth Technology Manufactures catheters for treatment of vascular diseases | Health Technology |
















